Skip to main content
Gentian Diagnostics ASA logo

Gentian Diagnostics ASA — Investor Relations & Filings

Ticker · GENT ISIN · NO0010748866 LEI · 5967007LIEEXZXHNM861 OL Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2021-04-16 Investor Presentation
Country NO Norway
Listing OL GENT

About Gentian Diagnostics ASA

https://www.gentian.com/

Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.

Recent filings

Filing Released Lang Actions
First quarter 2021 report
Investor Presentation Classification · 98% confidence The document is titled 'Q1 Presentation 2021 April 16th, 2021' and contains slides detailing financial highlights for 'Q1 2021' (including Sales, Revenues, OPEX, EBITDA comparisons to 1Q 2020), growth opportunities, and an outlook. This structure is characteristic of an Investor Presentation (IP) used to discuss recent quarterly performance and strategy with investors. It is not a formal regulatory filing like a 10-K or a standalone Earnings Release (ER), but rather a detailed presentation deck supporting the results. The content is too detailed for a simple Report Publication Announcement (RPA).
2021-04-16 English
First quarter 2021 report
Report Publication Announcement Classification · 99% confidence The document explicitly states it is the "First quarter 2021 report" and immediately lists key financial highlights (record sales revenue, growth percentages) for that period. This strongly indicates an Earnings Release (ER) which provides the initial announcement of periodical financial results. Although it mentions that the full report and presentation are enclosed, the primary content provided is the summary of results, fitting the definition of an ER. It is too detailed for a simple RPA, and it is not the comprehensive quarterly report (IR).
2021-04-16 English
Presentation of 2021 first quarter results for Gentian Diagnostics AS
Report Publication Announcement Classification · 98% confidence The document text is very short (581 characters) and explicitly announces an upcoming event: the presentation of the '2021 first quarter results' for Gentian Diagnostics AS, including the date, time, and a registration link for a webcast. This is not the actual results report (which would likely be an ER or IR), but an announcement about the presentation/webcast of those results. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that information will be presented or is available often points to a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this is specifically about the publication/presentation of financial results, RPA is the most fitting category, as it signals the release event rather than containing the full financial data itself.
2021-04-12 English
Publication of NT-proBNP patent application
Regulatory Filings Classification · 100% confidence The document is a short announcement (1333 characters) from Gentian Diagnostics regarding the publication of a patent application (PCT Application No. PCT/EP2020/072720) for an NT-proBNP assay. It details the technology and future launch plans (4Q 2021). This is not a comprehensive financial report (like 10-K or IR), nor is it a standard earnings release (ER) or management discussion (MDA). It concerns intellectual property and future product development, which is a specific type of corporate update. Since there is no specific category for 'Patent Publication' or 'IP Update', and it is a formal announcement of a specific corporate event/filing, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory/corporate announcement, or potentially 'Capital/Financing Update' (CAP) if the IP is viewed as a core asset update, but RNS is the safer fallback for specific, non-financial regulatory events. Given the focus on a patent application publication, RNS is the most appropriate general regulatory announcement code.
2021-02-18 English
4Q 2020 Results and preliminary annual report
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the fourth quarter and full year 2020 for Gentian Diagnostics AS. It includes detailed financial statements (sales, geographic/product splits, COGS, EBITDA, balance sheet), operational summaries, market development updates, and future outlooks. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year (quarterly/annual performance review). Therefore, it fits the definition of an Interim/Quarterly Report. Q4 2020
2021-02-11 English
4Q 2020 Results and preliminary annual report
Investor Presentation Classification · 98% confidence The document is titled "Q4 Presentation 2020" and contains detailed financial highlights for Q4 2020 and the full year 2020, including tables for Sales, Revenues, COGS, OPEX, and Cash Flow. It also includes sections on Growth Opportunities, Strategy, and Outlook. This structure is characteristic of an Investor Presentation (IP) used to communicate periodic financial results and strategic updates to investors, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). Since it is a detailed presentation summarizing quarterly performance and future outlook, 'Investor Presentation' (IP) is the most appropriate classification.
2021-02-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.